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Abstract: Macrophages are natural target cells of human immunodeficiency virus type 1 (HIV-1).
Viral replication appears to be delayed in these cells compared to lymphocytes; however, little is
known about the kinetics of early post-entry events. Time-of-addition experiments using several
HIV-1 inhibitors and the detection of reverse transcriptase (RT) products with droplet digital
PCR (ddPCR) revealed that early replication was delayed in primary human monocyte-derived
macrophages of several donors and peaked late after infection. Direct imaging of reverse-transcription
and pre-integration complexes (RTC/PIC) by click-labeling of newly synthesized DNA further
confirmed our findings and showed a concomitant shift to the nuclear stage over time. Altering the
entry pathway enhanced infectivity but did not affect kinetics of viral replication. The addition
of viral protein X (Vpx) enhanced productive infection and accelerated completion of reverse
transcription and nuclear entry. We propose that sterile alpha motif (SAM) and histidine/aspartate
(HD) domain-containing protein 1 (SAMHD1) activity lowering deoxyribonucleotide triphosphate
(dNTP) pools is the principal factor delaying early HIV-1 replication in macrophages.
Keywords: human immunodeficiency virus; primary macrophages; reverse-transcription complex;
pre-integration complex; replication kinetics; SAMHD1
1. Introduction
Human immunodeficiency virus type 1 (HIV-1) primarily infects and replicates in cluster of
differentiation 4 positive (CD4+) T cells. However, macrophages also constitute a relevant natural
target cell of the virus and are a crucial vehicle of viral spread within the infected organism [1].
In contrast to lymphocytes, they are largely refractory to the cytopathic effects of productive infection.
Accordingly, macrophages can sustain viral replication over extended periods of time in culture and
in vivo [2–5], and are, thus, considered important viral reservoirs.
Kinetics of individual HIV-1 replication steps in T-cell lines and primary CD4+ lymphocytes
were previously analyzed in detail (e.g., [6–9]). A particular focus of interest was on early post-entry
events—from cytosolic entry of the viral capsid over reverse transcription of the viral genome to its
transport to and integration into the host cell DNA—which establish persistent infection and are key
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targets of intrinsic cellular restriction factors. A recent report analyzed the timing of the various stages
of viral replication at the single-cell level in the MT-4 T-cell line. Reverse transcription of the viral
RNA genome was found to be completed within ca. 14 h post infection (p.i.), while integration of the
resulting viral complementary DNA (cDNA) into the host cell genome occurred ~19 h p.i., and peak
virus production was observed between 30 h and 40 h p.i. [9]. Similarly, early post-entry replication
steps in primary lymphocytes were found to occur within the first 24 h of infection, and viral progeny
production from these cells was readily detectable at 40 h p.i. [7,10].
In contrast, HIV-1 replication kinetics in primary macrophages are much less characterized.
Productive HIV-1 replication in these cells appears to be significantly slower compared to CD4+ T
lymphocytes. Initial studies of HIV-1 infection of macrophages in vitro using clinical virus isolates
and various laboratory strains followed virus production over multiple rounds of replication. These
analyses revealed very low levels of p24 capsid (CA) antigen in supernatants two days post infection,
and peak levels of virus production from the initial infection were only reached between days five
and eight post inoculation [11–13]. Furthermore, the efficiency of HIV-1 infection also depends on the
pathway of differentiation and type of macrophage polarization [14,15]. Semi-quantitative PCR-based
approaches to detect different genome replication intermediates revealed strong-stop cDNA as the first
product of HIV-1 reverse transcriptase (RT) at 6 h p.i. in macrophages and T-cell lines alike. However,
peak levels of RT products were reached only after 48 h in macrophages, and no evidence for a second
round of infection was observed in these cells within the observation time [16,17]. More recent studies
reported the appearance of post-integration stages at late times post infection in macrophages (96 h
p.i. [18]), also pointing to delayed viral replication. Taken together, the work from many labs indicates
slow and inefficient HIV-1 replication in primary macrophages; however, a consistent analysis of
individual replication steps throughout several days of infection, as performed in the case of T cells,
is missing.
The comparatively low level of deoxyribonucleotide triphosphates (dNTPs) in the cytosol of
post-mitotic macrophages was identified as one important reason for the inefficient HIV-1 replication
in these cells [19–21]. Low dNTP levels are caused, at least in part, by the activity of the cellular
phosphohydrolase, sterile alpha motif (SAM) and histidine/aspartate (HD) domain-containing
protein 1 (SAMHD1), which is highly expressed in cells of the myeloid lineage [22–25]. SAMHD1 is
counteracted by the viral protein X (Vpx), which is present in HIV-2 and simian immunodeficiency
virus (SIV), but not in HIV-1 [26,27]. Accordingly, HIV-2 and SIV replicate more efficiently in primary
human macrophages than HIV-1 [28], and HIV-1 replication can be experimentally enhanced by
SAMHD1 depletion through knock-down or Vpx expression [25,29,30].
HIV-1 infection of macrophages is frequently scored at 24–48 h, but the respective studies
usually employ strategies to enhance infection. Pseudotyping of viral particles with the glycoprotein
of vesicular stomatitis virus (VSV-G) directs HIV-1 entry toward clathrin-mediated endocytosis,
and significantly enhances the efficiency of macrophage infection [31]. Additionally, or alternatively,
intracellular dNTP levels are often manipulated by supplementing deoxyribonucleoside precursors or
via Vpx-mediated depletion of SAMHD1. However, the effect of these experimental modifications
on the dynamics of individual replication events is largely neglected. Despite the extensive
characterization of the effects of Vpx on macrophage infection/transduction and its interaction with
SAMHD1 (e.g., [23,25,28,29,32]), the alteration of HIV-1 early post-entry kinetics upon SAMHD1
degradation is yet to be analyzed.
Here, we present a systematic analysis of the kinetics of the early HIV-1 replication steps in
primary human monocyte-derived macrophages (MDM) from multiple donors over several days post
infection. We also addressed the effects of VSV-G pseudotyping or increasing dNTP availability on the
timing of these steps. For this, we complemented inhibitor time-of-addition experiments with sensitive
digital droplet PCR (ddPCR) quantitation of different RT products and with imaging of intracellular
productive subviral complexes. Early HIV-1 replication peaked at 48–60 h after infection. Time and
pathway of entry did not affect the time course of early replication, while treatment with Vpx not only
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resulted in enhanced reverse transcription, but also accelerated early viral replication. These results
indicate that nucleoside triphosphate availability or SAMHD1 activity are the main limiting factors for
the early HIV-1 replication steps in macrophages.
2. Materials and Methods
2.1. Cell Culture
Human embryonic kidney 293T cells (HEK293T) and TZM-bl indicator cells [33,34] were cultured
at 37 ◦C and 5% CO2 in Dulbecco’s modified Eagle medium (DMEM; Life Technologies, Carlsbad, CA,
USA), supplemented with 10% fetal calf serum (FCS; Biochrom GmbH, Berlin, Germany), 100 U/mL
penicillin, and 100 µg/mL streptomycin. For isolation of monocyte-derived macrophages (MDMs),
human peripheral blood mononuclear cells (PBMC) were isolated from buffy coats by Ficoll density
gradient centrifugation using SepMate tubes (StemCell Technologies, Vancouver, BC, Canada). Buffy
coats were obtained from healthy anonymous blood donors at the Heidelberg University Hospital
Blood Bank according to the regulations of the local ethics committee. PBMC were seeded in
Roswell Park Memorial Institute medium 1640 (RPMI; Life Technologies), supplemented with 10%
heat-inactivated FCS and antibiotics, and incubated for 2 h at 37 ◦C. Cells were washed three times to
remove non-adherent cells, and adhered monocytes were subsequently cultured and differentiated
into MDMs in RPMI 1640 supplemented with 10% heat-inactivated FCS, antibiotics, and 5% human
AB serum (Sigma-Aldrich, St. Louis, MO, USA) for 7–10 days; medium was replaced every three days.
In polarization experiments, CD14+ monocytes were isolated from PBMC by negative selection
using magnetic beads (Monocyte Isolation Kit II; Miltenyi Biotech, Bergisch Gladbach, Germany),
seeded in RPMI 1640 supplemented with 10% heat-inactivated FCS and antibiotics, and subsequently
differentiated and polarized into M1 or M2a macrophages by adding to the medium 50 ng/mL
granulocyte-macrophage colony-stimulating factor (GM-CSF; PeproTech, Hamburg, Germany) and
20 ng/mL interferon gamma (IFNγ; R&D systems, Minneapolis, MN, USA), or 50 ng/mL M-CSF
(PeproTech) and 20 ng/mL interleukin 4 (IL-4; R&D systems), respectively.
2.2. Plasmids
The proviral HIV-1 plasmid pNL4-3 was described elsewhere [35]. The derivative pNL4-3∆Env
contains a premature stop codon in the Env open reading frame (ORF) resulting from a 2-bp fill-in
of an NdeI site. Plasmid pEnv-4059 encoding an R5-tropic Env from a clinical HIV-1 isolate was
kindly provided by R. Swanstrom (University of North Carolina, Chapel Hill, NC, USA) [36]). Plasmid
pVpr.IN.enhanced GFP (eGFP) encoding a Vpr.IN.eGFP fusion with a protease cleavage site between
Vpr and IN was kindly provided by A. Cereseto (CIBIO, Mattareo, Italy [37]). Plasmid pMD2.G
encoding the vesicular stomatitis virus glycoprotein (VSV-G) was generated by D. Trono (EPFL,
Lausanne, Switzerland) and obtained through Addgene (#12259). Plasmid pcDNA3.1Zeo+ mammalian
expression vector was obtained from Thermo Fisher Scientific (Waltham, MA, USA). The packaging
plasmid containing the Vpx-interacting motif in group-specific antigen protein (Gag; p∆R8.9 NSDP)
and the plasmid encoding Vpxmac239, pcDNA.Vpxmac239, were described previously [38,39].
2.3. Antisera and Reagents
All standard reagents, unless indicated otherwise, were purchased from common commercial
sources. In-house rabbit and sheep polyclonal antisera against HIV-1 CA were raised against
purified recombinant protein. Monoclonal anti-CA antibody from hybridoma cell line 183 clone
H12-5C (MAK183) was obtained through the acquired immune deficiency syndrome (AIDS) Research
and Reference Reagent Program, Division AIDS, NIAID, and purified in-house. Goat anti-rabbit
immunoglobulin G (IgG; heavy and light chain (H + L)) conjugated to horseradish peroxidase
was purchased from Dianova (Hamburg, Germany). Mouse monoclonal laminA/C antibody
(sc-7292) was purchased from Santa Cruz (Heidelberg, Germany). Affinity purified anti-SAMHD1
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antibody (12586-1-AP) was purchased from Proteintech Inc (Chicago, IL, USA). Mouse monoclonal
anti-α-tubulin antibody (T5168) was purchased from Sigma-Aldrich. Mouse monoclonal anti-CD11b
conjugated to phycoerythrin (PE) and mouse monoclonal anti-CD163 conjugated to fluorescein
isothiocyanate (FITC) were purchased from Miltenyi Biotech. Alexa Fluor-labeled secondary antibodies
were purchased from Thermo Scientific Laboratories. Secondary antibodies conjugated with infrared
dye IRDye700/800 used for immunoblot were purchased from Rockland Antibodies and assays
(Limerick, PA, USA) or from LI-COR (Lincoln, NB, USA). A 10 mM stock solution of raltegravir
(RAL; AIDS Research and Reference Reagent Program, Division of AIDS, NIAID) was prepared in
water and stored in aliquots at −20 ◦C. Additionally, 10 mM stock solutions of efavirenz (EFV; AIDS
Research and Reference Reagent Program, Division of AIDS, NIAID), maraviroc (MVC; Sigma-Aldrich),
and PF-3450074 (PF74; Sigma-Aldrich) were prepared in dimethyl sulfoxide (DMSO) and stored
at −20 ◦C. Furthermore, 50 mM stock solutions of 2′-deoxyadenosine (dA; Sigma-Aldrich, D668),
2′-deoxythymidine (dT; Sigma-Aldrich, T1895), and 2′-deoxycytidine (dC; Sigma-Aldrich, D0776)
were prepared in water and stored at −20 ◦C. A 50 mM stock solution of 2′-deoxyguanosine (dG;
Sigma-Aldrich, D7145) was prepared in 1 M ammonium hydroxide and stored at −20 ◦C.
2.4. Virus Production and Characterization
Viral particles were produced in HEK293T cells transfected with 70 µg of plasmid DNA
(per T 175 cm2 flask) using calcium phosphate, following standard procedures. Pseudotyped R5
tropic HIV-1 viral particles were generated by co-transfection of pNL4-3∆Env with pEnv-4059 at
a molar ratio of 4.5:1. VSV-G pseudotyped particles were prepared using the same molar ratio
but using pMD2.G instead of HIV-1 Env. For producing viral particles labeled with IN.eGFP,
pNL4-3∆Env was co-transfected together with pEnv-4059 and pVpr.IN.eGFP at a molar ratio of 4.5:1:1.
Lentiviral vectors lacking or carrying Vpxmac239 were produced by co-transfection of pcDNA3.1Zeo+
or pcDNA.Vpxmac239, respectively, with pMD2.G and p∆R8.9 NSDP at a molar ratio of 1.4:1.4:2.
Particle-containing supernatants were collected 48 h after transfection, filtered through 0.45-µm
nitrocellulose filters, and concentrated by ultracentrifugation through a 20% (w/w) sucrose cushion
(SW28 rotor, 28,000 rpm, 1.5 h). Particle pellets were gently resuspended in phosphate-buffered
saline (PBS) containing 10% heat-inactivated FCS and 10 mM Hepes (pH 7.5), before being stored
in aliquots at −80 ◦C. For ddPCR experiments, particle-containing supernatants were treated prior
to ultracentrifugation with 15 U/mL DNAseI (Sigma-Aldrich) and 10 mM MgCl2 for 2.5 h at 37 ◦C.
Virion-associated RT activity was determined by an SYBR Green-Based Product Enhanced Reverse
Transcription Assay as a measure for particle amounts [40]. Concentrations of CA were determined
by an in-house enzyme-linked immunosorbent assay (ELISA). For this purpose, 96-well ELISA
plates were coated with purified MAK183 anti-CA antibody (diluted in PBS) overnight in a humid
chamber. Following blocking with 10% FCS in PBS, plates were incubated with samples, previously
diluted in 0.1% Tween/PBS, and incubated overnight in a humid chamber. Afterwards, an in-house
polyclonal rabbit anti-CA antiserum diluted 1:1000 in 10% FCS/PBS/1% Tween was added, and antigen
detection was performed by incubation with anti-rabbit IgG (H + L) secondary antibody conjugated
with horseradish peroxidase. Tetramethylbenzidine (TMB; Thermo Fisher Scientific) was added
as a substrate, and absorbance readings were performed at 450 nm to detect enzymatic activity.
Purified recombinant HIV-1 CA of known concentration was used as a standard. Infectivity of
HIV-1 particles was characterized by titration on TZM-bl indicator cells followed by detection of
β-galactosidase-expressing cells at 48 h p.i., as previously described [34].
2.5. Virus Infection and Transduction, Click-Labeling, and Immunostaining
To visualize HIV-1 reverse-transcription and pre-integration complexes (RTC/PIC), MDMs
were seeded in eight-well LabTek chamber slides (#155411, Thermo Scientific, Waltham, MA,
USA) and infected with 100 ng of CA of HIV-1 (IN.eGFP) in complete RPMI containing 10 µM
5-ethynyl-2´-deoxyuridine (EdU; Thermo Scientific). At 24 h post infection (p.i.), 5 µM MVC
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(Sigma-Aldrich) was added together with 10 µM EdU in fresh RPMI 1640, and infection was continued
at 37 ◦C for the time indicated in the description of the experiment. At the end of the incubation
period, cells were washed with PBS and fixed in 4% paraformaldehyde (PFA; Electron Microscopy
Sciences, Hatfield, PA, USA) for 15 min at room temperature. Subsequently, cells were washed and
permeabilized in 0.5% (v/v) Triton X-100 for 15 min and washed again. Cells were washed twice with
3% bovine serum albumin (BSA; w/v, in PBS) and click-labeling was performed for 30 min at room
temperature in the dark using the Click-iT EdU Alexa Fluor 647 Imaging Kit (Thermo Fisher Scientific),
following the manufacturer’s instructions. Click-labeling mix was removed, and cells were washed
three times. For immunostaining, cells were blocked in 3% BSA for 1 h, followed by incubation with the
primary antibody diluted in PBS and 0.5% BSA for 1h at room temperature in the dark. Samples were
then washed three times for 2 min with PBS, and then incubated with the corresponding secondary
antibody in PBS/0.5% BSA for 1 h at room temperature.
2.6. Infectivity Assays and Time-of-Addition Experiments
For assessment of productive infection, approximately 10,000 MDMs/well were seeded in black
96-well plates (Costar #3606). Cells were infected in triplicate or quadruplicate with 15 ng of CA of
HIV-1NL4-3 pseudotyped with R5-tropic Env or VSV-G per well (an amount previously determined
in infectivity experiments using a similar number of MDMs from various donors and different CA
concentrations to be equivalent to a multiplicity of infection (MOI) of ~0.1 with some donor-to-donor
variability). After 24 h, medium was replaced and 5 µM MVC (Sigma-Aldrich) was added to block
further entry events. Then, 5 µM EFV, 5 µM RAL (AIDS Research and Reference Reagent Program,
Division AIDS, NIAID), 2 µM PF74 (Sigma-Aldrich), or the equivalent volume of DMSO was added
to the cultures at different time points, as indicated in the respective experiments. At 72 h p.i.,
medium was replaced, and inhibitor was added to samples from all time points, except for the
DMSO control samples. Infection was stopped at day 6 p.i. by treatment with 4% PFA for 90 min,
and newly synthesized Gag was detected by immunostaining using anti-CA (rabbit) antiserum;
nuclei were counterstained with Hoechst (Thermo Fisher Scientific). Plates were imaged in a fully
automated screening microscope, as explained below. For experiments involving Vpx-mediated
SAMHD1 degradation, cells were transduced with virus-like particles (VLP) corresponding to 150 mU
of RT lacking or carrying Vpxmac239 12 h before HIV-1 infection. In experiments where extracellular
nucleosides were added, medium supplemented with 100 µM of dA, dC, dG, and dT was added to the
cells 2 h before infection.
2.7. Detection of HIV-1 RT Products with ddPCR
To detect HIV-1 RT products, MDMs were seeded in six-well plates and infected with 50 ng of CA
of HIV-1NL4-3 pseudotyped with R5-tropic Env. For experiments involving Vpx-mediated SAMHD1
degradation, cells were transduced with 300–500 mU of RT VLP lacking or carrying Vpxmac239 12 h
before infection. Cells were harvested at different time points p.i. as indicated. For DNA extraction,
cells were washed with PBS, detached from the plates, and spun down (5000 rpm, 5 min); cell pellets
were lysed overnight at 55 ◦C using an in-house lysis buffer (10 mM Tris-HCl pH9.0, 0.1% Tritron X-100,
400 µg/mL proteinase K (Thermo Fisher Scientific), and double-distilled water (ddH2O)). Proteinase
K was inactivated at 95 ◦C for 10 min, and lysates were stored at −20 ◦C or diluted and used for
detection of RT products. Digital droplet PCR (ddPCR) was employed to detect HIV-1 RT products
from infected cells, as described previously [41]. Early and late RT products were detected with
two sets of primers/probe annealing to the 5′ long terminal repeat (LTR) or to the gag ORF of the
genome, respectively. Additionally, another set of primers/probe to detect 2-LTR circles was used.
The single-copy host gene encoding ribonuclease P protein subunit p30 (RPP30) was also quantified to
normalize sample input (refer to Table 1 for sequences of primers and probes). Furthermore, 20-µL
reactions containing 2–4 µL of diluted lysate, 900 nM each primer, 200 nM probe, 1× ddPCR Supermix
for probes (no dUTP) (BioRad, Hercules, CA, USA), and water were prepared for each target and
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sample. Subsequently, droplets were generated using droplet generation oil for probes (BioRad),
and immediately transferred to a 96-well microplate, as described previously [42]. PCR amplification
was performed using the following program: initial denaturation and stabilization at 95 ◦C for 10 min,
40 cycles of denaturation at 94 ◦C for 30 s, and annealing/extension at 57 ◦C for 60 s, followed by
10 min at 98 ◦C. Subsequently, droplets were sorted and analyzed in a QX200 droplet reader (BioRad)
using the software QuantaSoft v1.6 (BioRad) and the settings for absolute quantification. Results were
analyzed using the same software, and copy numbers were normalized to the copy numbers of the
housekeeping gene.
Table 1. List of sequences and source of primers and probes used to detect human immunodeficiency
virus type 1 (HIV-1) reverse transcriptase (RT) products with digital droplet PCR (ddPCR). LTR—long
terminal repeat; Fw—forward; Rv—reverse; FAM—fluorescein amidite; BHQ1—black hole quencher 1.
Target Sequence (5′–3′) Reference
5′-LTR Fw TTAAGCCTCAATAAAGCTTGCC
[43]5′-LTR Rv GTTCGGGCGCCACTGCTAG
5′-LTR Probe FAM–CCAGAGTCACACAACAGACGGGCA–BHQ1
Gag Fw CATGTTTTCAGCATTATCAGAAGGA
[44]Gag Rv TGCTTGATGTCCCCCCACT
Gag Probe HEX—CCACCCCACAAGATTTAAACACCATGCTAA–BHQ1
2-LTR Fw CTAACTAGGGAACCCACTGCT
[45]2-LTR Rv GTAGTTCTGCCAATCAGGGAA
2-LTR Probe FAM—AGCCTCAATAAAGCTTGCCTTGAGTGC–BHQ1
RPP30 Fw GATTTGGACCTGCGAGCG
[42]RPP30 Rv GCGGCTGTCTCCACAAGT
RPP30 Probe FAM–CTGACCTGAAGGCTCT–BHQ1
2.8. Flow Cytometry
To analyze macrophage differentiation and polarization, cells were washed and detached using
StemPro Accutase (Thermo Fisher Scientific) for 30 min at 37 ◦C. Cells were then fixed in 4% PFA for
15 min, washed twice with PBS, and spun down. Pellets were resuspended in PBS and incubated
with anti-CD11b-PE or anti-CD163-FITC for 1 h on ice, protected from light. Subsequently, cells were
washed twice, and analyzed using an FACS Calibur flow cytometer (BD Biosciences, Franklin Lakes,
NJ, USA). Unstained cells were used as a control for gating. Results were analyzed with the software
FlowJo v10 (FlowJo, LLC, Ashland, OR, USA).
2.9. SDS-PAGE and Western Blot
Cells were washed with PBS and lysed in 3× Laemmli SDS buffer at 95 ◦C for 10 min. Lysates
were separated by SDS polyacrylamide gel electrophoresis (PAGE) and proteins were transferred to
a methanol-activated polyvinylidene fluoride (PVDF) membrane (Merck Millipore, Burlington, MA,
USA). SAMHD1 and α-tubulin were detected by probing the membrane with anti-SAMHD1 and
anti-α-tubulin antibodies, followed by secondary antibodies coupled to IRDye 700/800 (Rockland
Antibodies, Limerick, PA, USA). Fluorescent signals were detected using a LI-COR Odyssey CLx
scanning system. To quantify band intensities, blots were analyzed using the Odyssey Image Studio
v5.2 software (LI-COR).
2.10. Microscopy
Three-dimensional (3D) image series were acquired with a Perkin Elmer Ultra VIEW VoX 3D
spinning disk confocal microscope (SDCM) using a 100× oil immersion objective (numerical aperture
(NA) 1.4) (Perkin Elmer, Waltham, MA, USA). Z-stacks with a spacing of 200 nm were acquired in
the 405-, 488-, 561-, and 640-nm channels. For scoring infectivity, after immunostaining, plates were
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imaged using a high-throughput wide-field Olympus IX-81 inverted microscope with the 10× air
immersion objective (NA 0.45). Images were recorded in the 4′,6-diamidino-2-phenylindole (DAPI)
and Cy5 channels using the ScanˆR/Xcellence software (Olympus, Tokyo, Japan). Sixteen positions
were acquired per well.
2.11. Image Analysis
Analysis of individual HIV-1 RTC/PIC in 3D volumes of single infected cells was performed with
Imaris 9.2 (Bitplane, Zürich, Switzerland). For this, images were deconvolved with Autoquant X3
(Media Cybernetics, Rockville, MD, USA) using constrained maximal likelihood estimation (CMLE)
with 10 iterations and signal-to-noise ratio (SNR) = 20. 3D reconstructions of deconvolved images were
done with Imaris, and IN.eGFP positive objects were identified using the spot detection function of the
software. Camera offset was subtracted, and spots were detected using an estimated XY diameter of
300 nm, together with a quality filter detecting the intensities at the center of the spot. Mean signal
intensities in the four recorded channels were measured.
To detect and quantify infected cells in images acquired with the automated system, we used a
previously published script in MatLab (MathWorks [46]). Briefly, objects were identified using the
Hoechst signals, and the difference in signal intensities between background and signals from actual
nuclei was used to generate a nuclear mask. This mask was used to segment the cytoplasm, and CA
signal intensities from the whole cell were measured. Mock-infected samples were used as a reference
to set an intensity threshold to distinguish between non-infected and infected cells.
3. Results
3.1. Early HIV-1 Replication Is Slow in Primary Macrophages
In order to study HIV-1 infection in primary human MDMs, terminally differentiated macrophages
were prepared from primary monocytes from healthy blood donors. Various protocols for macrophage
differentiation are used in the field, resulting in differently activated cells. Macrophage populations are
classified based on their immune activation status and cytokine production into M0 (non-polarized),
M1, and M2 cells [47]. It was reported that addition of certain cytokines or growth/differentiation
factors such as M-CSF (commonly associated with M2 macrophages) or GM-CSF (commonly associated
with M1 macrophages) before or after infection may affect HIV-1 replication efficiency [14,15]. We,
therefore, analyzed whether macrophage differentiation into M0, M1, or M2 populations affected
HIV-1 infectivity. Monocytes were isolated from peripheral blood mononuclear cells (PBMC) and
differentiated into M0, M1, or M2a macrophages by the addition of human AB serum, GM-CSF and
IFNγ, or M-CSF and IL-4, respectively. The differentiation status of the resulting cell populations was
verified by determining surface levels of CD11b and CD163 using flow cytometry [48] (Figure S1A,
Supplementary Materials). Subsequently, cells were infected with HIV-1NL4-3-derived particles
pseudotyped with an R5-tropic envelope (Env) protein from a patient isolate [36]. At 24 h post
infection (p.i.), medium was removed and 5 µM of the HIV-1 entry inhibitor maraviroc (MVC) was
added to prevent further entry. At day 6 p.i., productive infection was assessed by detection of newly
synthesized viral protein using an antiserum against CA. In agreement with previous reports [15,49],
M1 macrophages were not efficiently infected; less than 3% of cells were scored as CA-positive.
Efficiency of HIV-1 infection in M0 and M2a macrophages was comparable, with ~8% CA-positive
cells detected in both cases (Figure S1B, Supplementary Materials). The following experiments were
performed in non-polarized (M0) primary macrophages generated from monocytes by stimulation
with human AB serum (termed MDM throughout the report).
In order to obtain a detailed timeline for post-entry steps, we performed single-round infection
and inhibitor time-of-addition experiments (Figure 1). MDMs were infected with R5-pseudotyped
HIV-1NL4-3. Pseudotyping ensured that infection was restricted to a single round as newly synthesized
particles lacked the viral Env proteins. At 24 h p.i., the tissue culture medium was changed and 5 µM
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MVC was added to prevent further entry events. Parallel cultures were then treated with specific HIV-1
inhibitors targeting either reverse transcription (efavirenz, EFV) or genome integration (raltegravir,
RAL). The small CA-binding molecule PF74 was used as an inhibitor of nuclear import. While high
concentrations of this compound (>10 µM) can impair reverse transcription, presumably by affecting
capsid stability, the lower concentration (2 µM) of PF74 used in our experiments was found to block
nuclear entry of subviral complexes without affecting reverse transcription [50–52]. The different
inhibitors were added at various time points post infection, spanning a period from 12 h to 72 h p.i.
(Figure 1A). Incubation of all samples was then continued for a further 72 h in the presence of the
respective inhibitor to ensure maximum HIV-1 antigen expression. Productive infection was assessed
at day 6 p.i. by immunofluorescence detection of newly synthesized Gag, using an antiserum against
the CA domain of the polyprotein.
As shown in Figure 1B, productively infected cells were clearly distinguishable from non-infected
cells (identified by Hoechst stain) based on CA signal intensities. An automated microscopic set-up
and data analysis pipeline was used to determine the proportion of cells infected under each condition.
The values obtained under inhibitory conditions were normalized to the proportion of infected cells
observed upon DMSO treatment to determine the resilience to the drugs at each time point of addition
(Figure 1C). Unexpectedly, loss of sensitivity to inhibitors of reverse transcription and integration
was largely parallel in these experiments. Although some donor-to-donor variation was observed
(Figure S1C, Supplementary Materials), very low levels of infection were detected when these inhibitors
were added in the first 24 h of infection. Roughly 50% of resistance was observed at 48 h p.i., and the
inhibitors showed no significant effect at 60 h p.i. or later, indicating that reverse transcription, nuclear
import, and viral cDNA integration into the host cell genome were all largely completed at this time.
The curve was similar for PF74; however, in this case, some resilience was observed already at 12 h p.i.
(Figure 1C). Taken together, these experiments indicate a lag time of 24–36 h during which completion
of HIV-1 reverse transcription and/or integration is not detectable in MDMs, and show that post-entry
events are completed between 48 h and 60 h post infection in these cells.
The lack of an apparent lag between completion of reverse transcription and integration suggested
that completion of reverse transcription and/or nuclear entry represent rate-limiting steps of HIV-1
replication in MDMs. In order to study kinetics of reverse transcription in more detail, RT products
from infected cells were quantitated at different time points p.i. using sensitive digital droplet PCR
(ddPCR) [41]. MDMs from different donors were infected with R5-pseudotyped HIV-1 and harvested
at various time points over a period of four days. Cell lysates were subjected to ddPCR using
specific primer combinations to detect early and late products of reverse transcription as well as 2-LTR
circles as a surrogate marker for viral cDNA nuclear import [53] (Figure 2A). Productive infection
was scored in parallel samples by immunofluorescence as before. Absolute copy numbers of all
targets positively correlated with the infection efficiency scored for the respective donor (Figure S2A,
Supplementary Materials). The peak of early RT product copy numbers was detected between 60 h
and 72 h p.i. After this time, copy numbers reached a plateau or dropped (Figure S2B, Supplementary
Materials; Figure 2B), suggesting degradation of non-integrated transcripts. Late RT products peaked
at 72 h p.i., followed by a plateau phase or decline (Figure S2B, Supplementary Materials; Figure 2B).
Copy numbers determined for 2-LTR circles were significantly less abundant and peaked at the
same time point as late RT products (Figure S2C, Supplementary Materials; Figure 2B). These results
indicate that reverse transcription is slow in macrophages compared to the time frame reported for
lymphocytes [17] and corroborate our initial conclusions from the time-of-addition experiments.
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1 
 
 
  Figure 1. Time course analysis of human immunodeficiency virus type 1 (HIV-1) early post-entry
events in primary macrophages. (A) Scheme of inhibitor time-of-addition experiments. (B,C)
Monocyte-derived macrophages (MDMs) from six donors in three independent experiments were
infected with R5-pseudotyped HIV-1NL4-3. At 24 h post infection (p.i.), medium was changed and
5 µM maraviroc (MVC) was added to prevent further entry events. At day 6 p.i., samples were fixed
and stained. (B) Productive infection was assessed by immunostaining with anti-p24 capsid (CA)
antiserum (yellow) and counterstaining with Hoechst (blue). Samples were imaged in an automated
screening microscope. Scale bars represent 50 µm. (C) Solutions of 5 µM efavirenz (EFV; purple line),
5 µM raltegravir (RAL; blue line), or 2 µM PF74 (orange line) were added at the indicated time points
to different samples. At 72 h p.i., medium was replaced in all samples by fresh medium containing
the respective inhibitors and infection was again scored at day 6 p.i. The mean proportion of infected
cells from triplicate samples of all donors in treated samples normalized to the respective dimethyl
sulfoxide (DMSO) control is shown. Error bars represent standard error of the mean (SEM). Refer to
Figure S1 (Supplementary Materials) to see the results for individual donors.
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2 
 
  Figure 2. Quantitation of reverse transcriptase (RT) products using digital droplet PCR (ddPCR).
MDMs from seven donors in four independent experiments were infected with R5-pseudotyped
HIV-1NL4-3. At 24 h p.i., medium was changed and 5 µM MVC was added. Cells were harvested at the
indicated time points and HIV-1 RT products were quantitated in cell lysates by ddPCR as detailed in
Section 2.7. (A) Scheme of the binding sites of the set of primers used for detection of early and late RT
products as well as 2-long terminal repeat (LTR) circles. Cellular RPP30 was used as a housekeeping
gene for normalization. (B) Copy numbers of early (5′-LTR; blue line) and late RT (Gag; red line)
products or 2-LTR circles (black line) were normalized to the copy numbers of the housekeeping gene
at different time points p.i. for each donor, and these values were subsequently normalized to the
highest absolute number detected. Each symbol represents the mean of all the donors. Error bars
represent SEM. Refer to Figure S2 (Supplementary Materials) to see individual infectivity data for all
donors in the parallel experiment.
3.2. Visualization of HIV-1 RTC/PIC Revealed Timeframe of Nuclear Translocation
The bulk analyses described above indicated that HIV-1 post-entry events in primary macrophages
occur slowly over a 2–3 day time course, and that completion of reverse transcription and/or
nuclear import of the viral genome (as assessed by the indirect readout of 2-LTR circle formation) are
rate-limiting steps in this process. For a more detailed characterization of the time course of RTC/PIC
nuclear import, we proceeded with direct visualization of RTC/PIC appearance and intracellular
distribution over the course of the infection cycle. We previously established a microscopy-based
approach, which allows us to detect individual active HIV-1 RTC/PIC within infected cells [50].
For this, RTC/PIC are marked by incorporation of the key protein component integrase (IN) fused
to eGFP [37] into the infecting virion. In order to identify productive subviral complexes within
newly infected cells, nascent viral cDNA is tagged by incorporation of the thymidine analog
5-ethynyl-2′-deoxyuridine (EdU), which can in turn be detected via click-labeling with fluorophores.
Active RTC/PIC are then identified in confocal micrographs based on the co-localization of EdU
click-label and IN.eGFP signals [50]. Nuclear PIC positive for EdU and IN.eGFP may represent
unintegrated or integrated proviral complexes.
MDMs from different donors were infected with IN.eGFP-labeled R5-pseudotyped HIV-1NL4-3
in the presence of 10 µM EdU. At 24 h, medium was changed and 5 µM MVC was added to prevent
further infection. Cells were fixed at various time points p.i. and click-labeled. Since we previously
observed CA associated with both cytoplasmic and nuclear RTC/PIC in MDMs [50], samples were
also stained with antibodies against CA. Anti-laminA/C immunostaining was performed to mark the
nuclear envelope. Cells were imaged by confocal microscopy and 3D volumes were reconstructed.
RTC/PIC detected were classified according to intracellular localization as (i) cytoplasmic; (ii) close to
the nuclear envelope; or (iii) within the nucleus (Figure 3A–D). Relative proportions of RTC/PIC at
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each of these localizations were quantitated based on 3D reconstructions of cells fixed at different time
points p.i. These results are summarized in Figure 3E,F.
 
3 
 
  Figure 3. Subcellular detection of HIV-1 reverse-transcription and pre-integration complexes
(RTC/PIC). MDMs from four donors in three independent experiments were infected with 100 ng of CA
of R5-pseudotyped HIV-1NL4-3 (IN.eGFP) in the presence of 10 µM 5-ethynyl-2′-deoxyuridine (EdU).
At 24 h p.i., medium was changed and further viral entry was blocked by 5 µM MVC. Cells were fixed at
24 (A), 36 (B), 48 (C), and 60 h p.i. (D), click-labeled, and immunostained with anti-CA antiserum (cyan);
the nuclear envelope was marked by immunostaining with anti-laminA/C antibody (white). EdU and
IN.eGFP signals in the merged panels are represented in red and green, respectively. Exemplary
complexes of different types are indicated by arrowheads: solid arrows indicate co-localizing EdU and
IN.eGFP signals; empty arrows identify HIV-1 complexes lacking EdU signals. Scale bars represent
5 µm. (E) Proportion of IN.eGFP-positive objects in n cells in three subcellular localizations at different
time points. Numbers of detected objects are given in parentheses. Proportions were compared using a
two-tailed Z-test (α = 0.05); *** p < 0.0001; ** p < 0.002; n.s.: not significant. (F) Proportion of IN.eGFP-
and EdU-positive objects from (E) in n cells in three subcellular localizations at different time points.
Numbers of detected objects are given in parentheses. Proportions were compared using a two-tailed
Z-test (α = 0.05); *** p < 0.0001; ** p < 0.005; * p = 0.022; n.s.: not significant.
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Only a minor proportion of all complexes detected were found to be EdU-positive at all times
(from ~1% at 24 h to a maximum of ~5% at 48 h p.i.), and the vast majority of IN.eGFP-positive
objects (>90%) were localized in the cytoplasm at all time points (Figure 3E,F). This may reflect
endosomal uptake without fusion and/or abortive entry without successful reverse transcription.
About 3% of all viral complexes were detected in close vicinity to the nuclear envelope already at
the earliest observation time point (24 h p.i.; Figure 3A,E), with a similar proportion detected at the
subsequent observation times. In contrast, only few objects (0.44% of total) were found within the
nucleus at 24 h p.i., and this proportion significantly increased over the following days to ~1.4% at
36 h (Figure 3B,E) and a maximum of ~3% at 48 h (Figure 3C,E).
When focusing exclusively on productive RTC/PIC (as defined by a positive EdU signal
co-localizing with IN.eGFP; see examples in Figure 3F), we observed a generally similar time course,
consistent with previous reports indicating that reverse transcription is not required for nuclear
import [54,55]. However, the relative proportion of productive nuclear PIC was significantly higher at
all time points analyzed. At 24 h p.i., 15% of all EdU-positive complexes were observed in the vicinity
of the nuclear envelope, and this number remained relatively stable over the rest of the observation
period. Roughly 10% of productive complexes were already inside the nucleus at 24 h p.i., while
this proportion was <1% for all INeGFP-positive objects (Figure 3E,F). The proportion of nuclear
EdU-positive PIC increased to 40% and >50% at 36 h and 48 h p.i., respectively, with no further changes
observed at 60 h p.i. (Figure 3D,F). In agreement with our previous observations in macrophages [50],
the vast majority (>90%) of productive nuclear PIC were found to be clearly CA-positive, with no
apparent difference between time points.
The relative fluorescence intensity of individual particles in the EdU channel is proportional to
the amount of EdU incorporated by the viral RT and, thereby, provides information on the progression
of reverse transcription (although a direct quantitative correlation between fluorescence intensity and
length of the nucleic acid is yet to be established). We, therefore, compared the distribution of signal
intensities of EdU-positive complexes detected at 48 h p.i. at the different subcellular localizations
(Figure S3, Supplementary Materials). In all cases, we observed a clear peak population with a
comparatively low signal intensity of 5000–10,000 a.u. over background; however, complexes with
considerably higher intensity were also detected. In the cytoplasm, complexes with intensities above
10,000 a.u. amounted to about 20%, with peak values up to ~100,000 a.u. and a mean signal intensity
of the whole population of ~8900 a.u. Complexes detected in the nucleus were clearly brighter on
average, with almost half of all complexes (~47%) displaying intensities >10,000 a.u., with maximum
intensities up to ~300,000 a.u. and a total mean intensity of 24,800 a.u. Whether this apparent shift to
higher intensity in the nucleus indicates that nuclear import is influenced by the progression of reverse
transcription, or that HIV-1 reverse transcription in MDMs is only completed in the nucleus cannot be
inferred from bulk time-lapse experiments and remains to be determined. Intriguingly, complexes
detected close to the nuclear envelope did not exhibit an intermediate phenotype, but fell almost
exclusively (95%) into the low-EdU-intensity class of <10,000 a.u., with a population mean of 4800 a.u.
3.3. Type and Time of Cell Entry Does Not Affect Replication Kinetics in Macrophages
Many studies addressing HIV-1 replication in macrophages employed pseudotyping of virus
particles with the glycoprotein of vesicular stomatitis virus (VSV-G) in order to increase infection
efficiency (e.g., [31,56,57]). In addition to enhancing entry efficiency, this strategy also results in
redirection of the viral entry pathway exclusively to clathrin-mediated endocytosis [58,59]. Since
an influence of the entry route on post-entry events is conceivable [59], we were interested in
determining the effect of this alteration on the time course of post-entry events. As a baseline,
we analyzed kinetics of entry mediated by the R5-tropic HIV-1 envelope in an inhibitor time-of-addition
experiment. The co-receptor antagonist MVC was added to MDM at different time points after infection,
and infectivity was scored by CA immunostaining at day 6 p.i. as in the previous experiments
(Figure 4A). At 4 h p.i., resistance to the addition of MVC was around 30% and a large fraction of viral
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particles were still blocked, in contrast to T-cell lines, where >50% of cell entry events occurred within
the first 2–4 h of infection [6,7]. Resilience to the inhibitory effects of MVC was around 50% at 8 h p.i.
with some variation between donors, and reached near completion at 24 h p.i. (Figure 4A), indicating
that the half-time for productive entry into primary macrophages is ca. 8 h.
 
4 
 
  Figure 4. Effect of time and type of cell entry on HIV-1 replication kinetics. (A) MDMs from four
donors were infected with R5-pseudotyped HIV-1NL4-3. Subsequently, 5 µM MVC or an equivalent
volume of DMSO was added to the medium at the indicated time points p.i. Medium was replaced,
and infection was continued in the presence of the inhibitor until day 6. Cells were fixed, and productive
infection was scored by CA immunostaining. Proportions of infected cells were normalized to
the highest proportion observed in the DMSO control. The graph shows mean values and SEM
from triplicates or quadruplicates of all donors after normalization. (B,C) Influence of entry route:
(B) MDMs from four donors were infected with R5- or vesicular stomatitis virus (VSV-G) pseudotyped
HIV-1NL4-3. At 24 h p.i., medium was changed, and infection continued until day 6 p.i. Cells were fixed,
and infectivity was scored as above. The graph shows mean values and SEM from the four samples.
Statistical significance was assessed with a non-paired two-tailed Mann–Whitney test; **** p < 0.0001.
(C) MDMs from the same donors as in (B) were infected with equal amounts of R5-pseudotyped (orange
lines) or VSV-G pseudotyped (blue lines) HIV-1NL4-3. After 24 h, medium was changed. Solutions of
5 µM EFV (left plot, solid lines) or 5 µM RAL (right plot, solid lines), or DMSO (dashed lines) were
added every 12 h until 72 h p.i. At this time point, medium was changed, and infection continued until
day 6 in the presence of the inhibitors. Infectivity was scored as before. Mean values from infectivity
values of the replicates of all donors and SEM are shown.
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To analyze the effect of the entry pathway on post-entry dynamics, MDMs were infected in
parallel with HIV-1 particles pseudotyped with either the R5-tropic HIV-1 Env or VSV-G, and cultures
were treated with EFV or RAL at different time points as above. Productive infection was again scored
at day 6 p.i. In line with previous reports [31,57], we observed that overall infection efficiency in
MDMs was enhanced roughly twofold upon pseudotyping with VSV-G (Figure 4B). The relative time
course of post-entry events as assessed by the acquisition of resilience toward RT or IN inhibitors,
however, was very similar for both viruses (Figure 4C). These findings argue against the route and
efficiency of cell entry being determinants of the slow post-entry dynamics in MDMs.
3.4. Low Availability of dNTPs Restricts HIV-1 Replication in MDMs
A low cytoplasmic dNTP concentration in macrophages (~130–250-fold lower than in resting or
activated CD4+ T cells [21]) was proposed to be a major obstacle to productive HIV-1 infection [60].
The triphosphohydrolase activity of the host protein SAMHD1 is important for maintaining low
dNTP levels in macrophages, and the protein was recognized as an important host cell restriction
factor of HIV-1 infection [23]. HIV-2 and SIV, but not HIV-1, express a protein termed viral protein
X (Vpx), which is able to overcome this restriction by mediating proteasomal degradation of human
SAMHD1 [29,30,61].
We assessed the effect of increasing intracellular dNTP levels on HIV-1 post-entry dynamics
in MDMs. For this, we followed two different approaches. In one set of samples, we supplemented the
tissue culture medium before and during infection with a high concentration of deoxynucleosides as
precursors for dNTP synthesis, as done previously [62]. In another set of experiments, we transduced
host cells with lentiviral vector particles carrying exogenously expressed Vpx from SIVmac239 before
infection, and compared the time course of post-entry events with that in cells pre-treated with control
particles lacking Vpx.
Firstly, we performed an inhibitor time-of-addition experiment in infected cells cultured in the
presence or absence of nucleosides added to the medium (100 µM each of all four deoxynucleosides
added 2 h before infection; Figure 5A, left bars, and Figure 5B). Nucleoside addition increased overall
infection efficiency of MDM nearly twofold compared to infection in the absence of deoxynucleosides
(Figure 5A, left). The time-of-addition experiment showed full sensitivity toward inhibition of reverse
transcription or integration for the initial 24–36 h p.i. under both conditions (Figure 5B). The number
of cells refractory to the inhibitors increased more rapidly in the presence of nucleosides than in the
control samples after this time (Figure 5B), reflecting the higher number of productively infected cells
and suggesting enhancement of reverse transcription activity. Again, the timeline of resilience against
EFV or RAL was similar in this experiment, suggesting that reverse transcription/nuclear import still
represent a bottleneck under these conditions (Figure 5B).
In a second set of experiments, MDMs were transduced with lentiviral vector particles either
lacking or carrying Vpxmac239 12 h before infection. Degradation of SAMHD1 was monitored by
immunofluorescence to determine the optimal time course and validate the decrease in SAMHD1 levels.
At 12 h p.i., >90% of the cells exposed to the Vpx-carrying particles lacked a detectable SAMHD1 signal
(Figure S4A, Supplementary Materials); these conditions were, thus, chosen for subsequent infection.
In agreement with previous reports (e.g., [23–25,29]), cells that underwent SAMHD1 degradation
displayed significantly higher infectability (ca. threefold increase) than cells treated with control
particles. This effect was slightly, but not significantly, enhanced further when infection was performed
with VSV-G pseudotyped virus (Figure 5A, right panel). Inhibitor time-of-addition experiments using
EFV or RAL (Figure 5C) revealed similar time courses for MDMs transduced with particles lacking
Vpx as observed in our previous experiments (compare Figure 1C). Again, overall infection levels
were higher in cells pre-exposed to Vpxmac239, as evident from the higher numbers of infected cells
observed in the DMSO control samples (dotted lines). Early replication events appeared to occur much
faster in cells pre-exposed to Vpxmac239 compared to control transductions. While, at the earliest time
points analyzed (up to 8 h p.i.), the difference between Vpxmac239-treated cells and control cells was
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minor, pronounced differences were observed at the later time points. At 12 h p.i., the majority of
Vpxmac239-exposed cells were refractory to the effect of both drugs, indicating that reverse transcription
and integration were already completed in a large proportion of infected cells at this time. After
24 h p.i., resilience in these cells reached nearly 100%. In contrast, cells treated with particles lacking
Vpx remained fully sensitive to both drugs up to ~36 h p.i. In summary, these results corroborate
that transduction of Vpx alleviates restriction to HIV-1 infection in macrophages and show that this is
reflected in the kinetics of early viral replication. 
5 
 
  Figure 5. Effect of deoxynucleoside addition or viral protein X (Vpxmac239)-mediated sterile alpha motif
(SAM) and histidine/aspartate (HD) domain-containing protein 1 (SAMHD1) degradation on early
HIV-1 replication. (A) MDMs were either pre-incubated or not with nucleosides (100 µM each) 2 h
prior to infection or transduced with HIV-1 virus-like particles (VLPs) lacking or carrying Vpxmac239
12 h prior to infection. Subsequently, cells were infected with R5- or VSV-G pseudotyped HIV-1NL4-3.
Infectivity was scored at day 6 p.i. by CA immunostaining. Error bars represent SEM of infection rates
from all the replicates of all the donors. Statistical significance was assessed by a non-paired two-tailed
Mann–Whitney test; **** p < 0.0001; *** p = 0.0001; n.s.: not significant. (B) MDMs from four donors
in two independent experiments were pre-incubated for 2 h in medium (dashed lines), or medium
supplemented with 100 µM deoxynucleosides (solid lines) and then infected with R5-pseudotyped
HIV-1NL4-3. At 24 h p.i., medium was changed and 5 µM MVC was added. Solutions of 5 µM EFV
(red lines) or 5 µM RAL (blue lines), or the equivalent volume of DMSO (gray lines) were added to the
cultures at the indicated time points and infectivity was scored at day 6 p.i. The graph summarizes
mean infectivity values from four donors, each measured in quadruplicate. Error bars represent SEM.
(C) MDMs from four donors in two independent experiments were transduced with HIV-1 VLPs
lacking (grey lines) or carrying (black lines) Vpxmac239. After 12 h, medium was changed, and cells
were infected in quadruplicates with R5-pseudotyped HIV-1NL4-3. Solutions of 5 µM EFV (left, solid
lines), RAL (right, solid lines), or DMSO (dashed lines) were added at the indicated time points. At day
6 p.i., the proportion of infected cells was scored by CA immunostaining. The graph summarizes mean
values from four donors, each measured in quadruplicate. Error bars represent SEM. The unexpected
effect of the addition of DMSO to the cultures in the first time points under native conditions (−Vpx)
was most likely caused by technical errors at the moment of infection.
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In order to characterize the effect of Vpx-mediated SAMHD1 degradation on the dynamics of
reverse transcription in more detail, we quantitated different RT products in samples from inhibitor
time-of-addition experiments by ddPCR, including early time points post infection. MDMs were
transduced with VLP lacking or carrying Vpxmac239 for 12 h. SAMHD1 depletion was validated by
immunoblot (Figure S4B, Supplementary Materials) and only samples from the two donors showing a
strong reduction of SAMHD1 levels upon Vpxmac239 transduction (>70% reduction of bulk protein
levels) were included in the analyses. Overall infection efficiency was very low for these donors (~2–3%
infected cells); however, in agreement with our previous observations, transduction of Vpxmac239
resulted in a nearly twofold increase of HIV-1 infection (Figure 6A).
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  Figure 6. Influence of SAMHD1 degradation on reverse transcription efficiency. MDMs from two
donors were transduced with VLPs lacking or carrying Vpxmac239. After 12 h, cells were infected with
R5-pseudotyped HIV-1NL4-3. At 24 h p.i., medium was replaced and 5 µM MVC was added. (A) At
day 6 p.i., infected cells were scored by CA immunostaining. Mean values and SD from quadruplicate
samples are shown. Statistical significance was assessed by a non-paired two-tailed Mann–Whitney
test (donor 30) or a non-paired two-tailed Student′s t-test (donor 31); ** p = 0.0018; n.s.: not significant.
(B,C) Cells infected with VLPs carrying Vpxmac239 cells were lysed at the indicated time points and RT
products were detected by ddPCR as described in Section 2.7. Absolute copy numbers of early (black
lines) and late RT (gray lines) products, and 2-LTR circles (C) at each time point p.i. were normalized
to the copy numbers of the housekeeping gene. Each symbol shape represents a donor.
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Copy numbers of early RT products did not only peak earlier upon prior transduction with
Vpxmac239-carrying particles (24 h vs. 48 h p.i.), but also reached higher levels than in cells transduced
with particles lacking Vpx (Figure 6B; Figure S5A, Supplementary Materials), suggesting that SAMHD1
degradation results in both more rapid and more efficient reverse transcription. Late RT products
peaked at 24 h p.i. in the presence of Vpxmac239 in the host cells (vs. 72 h p.i. in its absence), and again
were significantly higher (~3–20-fold higher) than in cells transduced with VLP lacking Vpx (Figure 6B;
Figure S5A, Supplementary Materials). Levels of 2-LTR circles were very low in control cells in
accordance with the low infection rates observed, and peaked at time points from 48–60 h dependent
on the donor, as previously observed (Figure S5B, Supplementary Materials). Exposure to Vpxmac239
enhanced the levels of 2-LTR circles detected; these replication byproducts continued increasing
over the whole observation time in the individual donors, suggesting that genome circularization of
non-productive complexes is slow compared to the enhanced rate of nuclear entry (Figure 6C).
To complement these results, we performed microscopic analyses of subviral complexes in cells
pre-treated with particles lacking or carrying Vpxmac239 at early time points p.i. Transduced cells were
infected with virus carrying IN.eGFP and subjected to EdU click-labeling for detection of nascent
viral cDNA. Cells were fixed at 12 and 24 h p.i., click-labeled, and immunostained with anti-CA and
anti-laminA/C antibodies. As observed in our previous experiments (compare Figure 3), the vast
majority of IN.eGFP-positive objects (>90%) were localized in the cytoplasm at both time points.
Proportions of IN.eGFP-positive objects in the vicinity of the nuclear envelope and within the nucleus
increased from 12 h to 24 h p.i. under both conditions (Figure 3.4A–E), but values were 2–3-fold higher
in all cases for the cells pre-exposed to Vpxmac239 compared to the corresponding value for the control
cells, indicating more rapid transport toward and into the nucleus. In agreement with our observation
that levels of early and late RT products at 24 h p.i. were greatly increased upon exposure of cells to
Vpxmac239, a higher proportion of IN.eGFP-positive objects displayed detectable EdU signals at this
time point (~20% vs. ~10% for cells treated with control particles; Figure 3.4F).
Again, only a minor proportion of objects in the cytoplasm or near the nuclear envelope, but the
majority of nuclear complexes (70–80%), were EdU-positive in all samples. While we refrained from a
detailed analysis of EdU signal intensity distributions because of the relatively low total number of
EdU-positive complexes detected in these experiments, increased reverse transcription upon Vpxmac239
exposure was also reflected in the higher mean EdU signal intensities observed under these conditions
(~5300 a.u. vs. ~2500 a.u. for control cells in the cytosol, and ~9100 a.u. vs. ~2400 a.u. in the nucleus)
(Figure S6, Supplementary Materials). Similar to findings in cells infected under native conditions,
>90% of active nuclear PIC showed strong CA signals when cells were exposed to Vpx.
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7 
 Figure 7. Detection of nascent viral complementary DNA (cDNA) by EdU click-labeling following
SAMHD1 degradation. MDMs from three donors were transduced with 150 mU of RT of VLPs lacking
(A,B) or carrying Vpxmac239 (C,D). After 12 h, cells were infected with R5-pseudotyped HIV-1NL4-3
(IN.eGFP) in the presence of 10 µM EdU. Cells were fixed at 12 (A,C) or 24 h p.i. (B,D) and click-labeled
as described in Section 2.5. CA (cyan) and laminA/C (white; labeling the nuclear envelope) were
detected by immunostaining; EdU and IN.eGFP signals in the overlays are represented in red and
green, respectively. Enlargements of the nuclear region are displayed in the top right panels. Examples
of individual RTC/PIC (i,ii) indicated in the merged panels are enlarged in the lower right. Note that
focal planes may differ between overview of the nuclear region and particle enlargement. Exemplary
complexes of different types are indicated by arrowheads: solid arrows indicate co-localizing EdU and
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IN.eGFP signals; empty arrows identify HIV-1 complexes lacking EdU signals. Scale bars represent
5 µm (overview) or 2 µm (enlargements). (E) Proportion of IN.eGFP-positive objects in n cells in
three subcellular localizations at the indicated time points in cells treated with plasmid cDNA or
Vpx VLPs. Numbers of detected objects are given in parentheses. Proportions were compared using a
two-tailed Z-test (α = 0.05); *** p < 0.0001; ** p < 0.002; * p = 0.01; n.s.: not significant. (F) Proportion of
IN.eGFP- and EdU-positive objects from (E) in n cells in three subcellular localizations at different time
points in the presence or absence of Vpxmac239. Numbers of detected objects are given in parentheses.
Proportions were compared using a two-tailed Z-test (α = 0.05); *** p < 0.0001; ** p < 0.005; * p = 0.01;
n.s.: not significant.
4. Discussion
In this study, we provide a detailed analysis of early post-entry replication dynamics of HIV-1
in primary human macrophages, in order to identify steps that explain the slow and inefficient
replication of the virus in this host cell type and to determine the effect of strategies frequently
employed to enhance macrophage infection in experimental settings regarding the dynamics of
events. The experiments were mostly performed with non-polarized (M0) macrophages, but similar
infectivity and infection kinetics (not shown) were obtained for M2a macrophages, while M1-polarized
macrophages were poorly infected with HIV-1.
Cytosolic entry of HIV-1 into differentiated macrophages, as assessed by inhibitor time-of-addition
experiments, occurred more slowly than known for CD4+ lymphocytes. While productive HIV-1
entry into T-lymphocytes is generally completed within 2–4 h [6,7], resilience against the entry
inhibitor MVC developed gradually with a half-time of roughly 8 h in MDMs in our experiments.
A possible cause for this difference may be the route of entry used for productive infection. Whereas,
in the case of CD4+ T cells, fusion at the plasma membrane [63] and possibly clathrin-mediated
endocytosis [64] were reported as relevant entry routes, the process is less characterized in
macrophages, and clathrin-independent uptake, e.g., macropinocytosis, may play a major role [65].
Dynamics and route of entry do not appear to be relevant for the slow replication in macrophages,
however, since altering efficiency and route of cell entry by pseudotyping viral particles with the VSV-G
glycoprotein did not notably affect the time course of subsequent replication steps, while enhancing
overall infection rate. In contrast, the early post-entry events from reverse transcription of the viral
RNA to integration represented a main bottleneck independent of the entry route, with reverse
transcription and integration being completed only between two and three days p.i. as assessed
by inhibitor time-of-addition experiments. Consistently, sensitive ddPCR detection of RT products
revealed peak levels of early and late reverse transcripts around 72 h p.i. Interestingly, we observed
no apparent lag phase between completion of reverse transcription and integration, suggesting that
completion of viral DNA synthesis and/or entry of subviral complexes through the nuclear pore
represent rate-limiting steps for early HIV-1 replication in macrophages.
These findings were corroborated and extended by quantitative microscopic analysis of productive
subviral complexes in infected cells, using a previously established method [50]. Consistent with
the low efficiency of HIV-1 infection generally observed in macrophages [11,66], the majority of
IN.eGFP-positive objects were detected in the cytosol and only a small minority were associated
with detectable products of reverse transcription. Furthermore, 90% or more of all intracellular
IN.eGFP-positive complexes were found to be cytoplasmic at all times, and only 5% of all intracellular
IN.eGFP-positive structures became EdU-positive during the course of three days. Thus, abortive
HIV-1 infection of MDMs mainly stalls prior to efficient reverse transcription, and replication may be
limited at the stage of cytosolic entry (despite using a highly efficient R5-tropic Env from a primary
brain-derived HIV-1 isolate [36]) and/or reverse transcription. In accordance with the findings from our
other experiments, the number of EdU-positive objects increased over the first two days of observation
and a gradual shift of objects into the nucleus occurred within that time frame. As observed earlier by
us [50], most of the nuclear complexes in macrophages were associated with a strong signal for the
viral CA protein.
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At the earliest detection time of 24 h p.i., a relatively high proportion of subviral complexes were
already observed close to the nuclear envelope. Although the resolution of confocal microscopy
does not allow to state with certainty that these complexes were directly associated with the
nuclear envelope, the data support the hypothesis that passage of viral complexes through the
nuclear pore presents a kinetic bottleneck, while trafficking toward the nuclear envelope appears
to be rapid. Our microscopic approach also allowed us to correlate the subcellular localization of
complexes with the EdU click-labeling signal intensity as a relative measure of reverse transcription.
Overall, a strong peak population of EdU-positive complexes displayed low EdU click-labeling
intensities, complemented by a broadly distributed population of higher intensity complexes.
Although the intensity levels cannot be directly correlated to the length of the respective RT
products, this finding points to a lag phase between early and late reverse transcription, resulting
in relative accumulation of complexes stalled at an early state of the process. Productive RTC/PIC
were detected at all subcellular localizations analyzed; however, while they represented a small
minority in the cytosolic area—consistent with a high number of non-productive uptake events
under these conditions—their proportion in the nucleus was much higher at all time points tested.
Although blocking reverse transcription does not prevent import of HIV-1 subviral complexes into the
nucleus [54,55], this observation may hint at a dynamic correlation between reverse transcription and
nuclear import. The proportion of EdU-positive complexes found in the nucleus increased from 11%
at 24 h to >50% of all productive RTC/PIC at later time points, while only ~3% of all IN.eGFP-positive
complexes reached the nucleus during this time period.
Nuclear PIC also displayed higher overall EdU click-labeling intensities than EdU-positive
complexes detected in the cytosolic area, suggesting that nuclear import kinetics is either correlated
to the progression of reverse transcription, or that reverse transcription may be completed within
the nucleus in this cell type. Interestingly, while a population of EdU click-labeling high-intensity
objects was present in the cytoplasm, as well as in the nucleus, complexes detected close to the nuclear
envelope almost exclusively displayed low-intensity EdU click-labeling signals. While this observation
needs to be interpreted with some caution due to the low number of complexes detected at that site
in our analyses (n = 92 in 172 cells from four donors), it would be in agreement with the hypothesis
that a delay or block of reverse transcription impairs nuclear import kinetics [67,68]. Alternatively,
this population may represent dead-end complexes with functionally unrelated or related defects in
reverse transcription and nuclear import. The inference of reverse transcription and nuclear import
dynamics from the microscopic data is currently limited by the fact that different samples fixed at
different time points are compared in these bulk experiments. A definitive conclusion concerning the
relationship between reverse transcription and nuclear import awaits the development of live-cell
compatible detection approaches suitable for single-particle tracking.
The stimulatory effect of Vpx-mediated SAMHD1 degradation on HIV-1 infection
efficiency in macrophages—presumably through increasing intracellular dNTP levels—is well
documented [23–25,29,69]. Our dynamic analyses and quantitative microscopy clearly show that
not only efficiency of reverse transcription (i.e., the number of productive complexes and the amount
of RT products) was enhanced, but also the kinetics of reverse transcription were much more rapid
in cells pre-exposed to Vpxmac239. These results support the conclusion that removal of this kinetic
obstacle—most likely by increasing dNTP levels in MDMs—is the underlying cause of the enhanced
infectivity observed under these conditions. This effect was much less obvious when deoxynucleosides
were added prior to infection, which only yielded increased RT products at 36 h p.i. and later.
This delayed effect may be due to the need for uptake and conversion into the dNTP, but could also
reflect a threshold dNTP level for rapid and efficient reverse transcription, which may be difficult to
achieve in the presence of SAMHD1.
Even upon SAMHD1 degradation, however, copy numbers of early and late RT products were still
low at 4–8 h in macrophages, not matching the fast time course observed for T cells [17,70]. We cannot
currently discriminate whether this simply reflects the increased contribution of the slow entry
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phase on the overall dynamics or points to a remaining post-entry lag phase under these conditions;
mathematical modeling of data with the aim of disentangling these aspects is currently under way.
A rapid loss of inhibitor sensitivity is seen for both EFV and RAL after 8 h with almost complete loss of
inhibition at 24 h in the presence of Vpxmac239, compared to 2–3 days required for completion of reverse
transcription and integration without pre-exposure to Vpx. Loss of inhibitor sensitivity occurred largely
in parallel for RT and IN inhibitors independent of Vpx addition, indicating that, even under conditions
where the rate of reverse transcription is significantly enhanced, reverse transcription and/or nuclear
entry remain rate-limiting. Time-resolved analysis of both processes will be needed to resolve the
actual block, but our combined data indicate that completion of reverse transcription and nuclear entry
may be more closely linked, and synthesis of HIV-1 cDNA may largely be completed at the nuclear
pore or inside the nucleus in primary human macrophages.
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